12
Nov
2025
Watch
The new 2028-2034 Multiannual Financial Framework: architecture and governance (debate)
Dear Chairman, health is a sector of strategic importance for the European Union, as also stated in the Draghi report. Quality health systems mean a productive population and lead to GDP growth, and the pharmaceutical industry is the most important export segment of the European economy. A few years ago, the European Health Union was proclaimed with great publicity and then it seemed that health would indeed become one of the top priorities of the European institutions. Unfortunately, we see that this is not the case, and the best indicator is the proposal for a new seven-year budget. There is no longer a specific EU4Health programme and health is mixed with other priorities, so we do not know how much money will really be allocated to it and everything is left to the discretion of the Commission, which is unacceptable. Europe needs strong and ambitious, secured funding for health and biotechnology, including strategic projects provided for in the Critical Medicines Act. Lessons learned from the poor experience of reducing health spending during the MFF review, this time we have to act differently. Investing in health care is not a cost. It is an investment in our resilience, in our economy and in the very future of Europe.